期刊文献+

雷帕霉素药物涂层支架对家猪冠状动脉NF-κB影响的研究 被引量:1

Expression of NF-κB on susscrota domestica coronary artery after rapamycin eluting stent implanting
下载PDF
导出
摘要 目的探讨核因子-κB(nuclear factor-kappa B,NF-κB)mRNA和蛋白是否参予介入后支架内再狭窄(in-stent restennosis,ISR)的发生发展以及雷帕霉素药物涂层支架(rapamycin eluting stent,RES)是否影响NF-κB mRNA和蛋白表达。方法将裸金属支架(bare metal stent,BMS)和RES按支架∶动脉比率(直径1.1~1.2∶1.0)随机植入猪冠状动脉前降支或回旋支,1个月后行冠状动脉造影并取材,冠脉定量造影术(quantity of coronary artery,QCA)分析平均血管直径、晚期血管丢失和径向狭窄,血管组织标本嗜伊红染色后测定支架血管段冠状动脉内膜最大厚度、内膜面积和支架段内血管腔面积,Rt-PCR检测NF-κB mRNA表达和Western blotting检测NF-κB蛋白表达。结果①与BMS组相比较,RES组平均血管直径显著改善(P<0.05),而晚期血管丢失和径向狭窄均显著减少(均P<0.05)。②BMS组和RES组均可见内膜完全覆盖支架,BMS组支架段内内膜最大厚度和内膜面积均显著大于RES组(均P<0.05)、血管腔面积显著小于RES组(P<0.05)。③正常血管段可见NF-κB mRNA和蛋白微量表达,与此相比,BMS组和RES组血管段NF-κBmRNA和蛋白表达均显著增强,不过,RES组血管段NF-κB mRNA和蛋白显著低于BMS组血管段。④内膜面积与NF-κB mRNA(r=0.349,P=0.001)和蛋白(r=0.417,P=0.001)呈显著正相关。结论NF-κB可能介导ISR进程,BMS可能通过促进NF-κB导致ISR而RES则可能通过抑制NF-κB减轻ISR。 ObjectiveTo elucidate whether nuclear factor kappa B(NF-κB) mRNA and its protein take part in the proceed of in-stent restennosis(ISR) and whether rapamycin eluting stent(RES) influences on their expression after stent embedding coronary artery of susscrota domestica. Methods According to the ratio of stent vs artery(diameter 1.1~1.2∶1.0) ,both bare metal stent(BMS) and RES were implanted in the anterior descending coronary or circumflex branch coronary. After 1 month,coronary arteriongraphy was finished to...
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第23期3421-3424,共4页 China Journal of Modern Medicine
基金 国家教育部"春晖"计划资助项目(Z2005-1-21008)
关键词 裸金属支架 雷帕霉素药物涂层支架 核因子-ΚB 支架内再狭窄 bare metal stent rapamycin eluting stent nuclear factor kappa B in-stent restennosis
  • 相关文献

参考文献10

  • 1YAMASAKI K,ASAI T,SHIMIZU M,et al.Inhibition of NF kappaB activation using cis-element‘decoy‘of NFkappaB bind-ing site reduces neointimal formation in porcine balloon-injured coronary artery model[].Circulation.2006
  • 2SCHILLINGER M,MINAR E.Restenosis after percutaneous angioplasty:the role of vascular inflammation[].Vasc Health Risk Manag.2005
  • 3Holmes DR Jr,Leon MB,Moses JW,et al.Analysis of1-year clinical outcomes in the SIRIUS trial:a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis[].Circulation.2004
  • 4Weisz G,Leon MB,Hol mes DR,et al.Two-year outcomes af-ter siroli mus-eluting stent i mplantation:results fromthe Siroli-mus-eluting stent in de novo native coronary lesions(SIRI US)trial[].Journal of the American College of Cardiology.2006
  • 5URBAN P,GERSHLICK A H,GUAGLIUMI G,et al.Safety of coronary sirolimus-eluting stents in daily clinical practice:one-year follow-up of the e-Cypher registry[].Circulation.2006
  • 6Dibra,A,Mehilli,J,Braun,S.Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting[].American Heart Journal.2005
  • 7Li JJ,,Nie SP,Zhang CY,et al.Is inflammation a contributor for coronary stent restenosis?[].Medical Hypotheses.2007
  • 8Altavilla D,Saitta A,Squadrito G,et al.Evidence for a role of nuclear factor-kappa B in acute hypovolemic hemorrhagic shock[].Journal of Surgery.2002
  • 9Kamimura M,Bea F,Akizawa T, et al.Platelet-derived growth factor induces tissue factor expression in vascular smooth muscle cells via activation of Egr-1[].Journal of Hypertension.2004
  • 10Takeshi Suzuki,Greg Kopia,Shin-ichiro Hayashi,et al.Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model[].Circulation.2001

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部